MyD88-dependent SHIP1 regulates proinflammatory signaling pathways in dendritic cells after monophosphoryl lipid a stimulation of TLR4

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 3858-3865

  Cekic, Caglar ^a,d   Casella, Carolyn R ^a   Sag, Duygu ^a,d   Antignano, Frann ^b,c   Kolb, Joseph ^a   Suttles, Jill ^a   Hughes, Michael R ^c   Krystal, Gerald ^b   Mitchell, Thomas C ^a  

^a University of Louisville School of Medicine   (United States)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; ENDOTHELIN 1; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHORYL LIPID A; PROTEIN SHIP1; REGULATOR PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BONE MARROW CELLS; DENDRITIC CELLS; ESCHERICHIA COLI; INFLAMMATION MEDIATORS; LIPID A; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHORIC MONOESTER HYDROLASES; SALMONELLA; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 79955041562     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001034     Document Type: Article

References (35)

1. Evans, J. T., C. W. Cluff, D. A. Johnson, M. J. Lacy, D. H. Persing, and J. R. Baldridge. 2003. Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529. Expert Rev. Vaccines 2: 219-229. (Pubitemid 36559927)
2. + T cells. J. Leukoc. Biol. 78: 1273-1280. (Pubitemid 41779233)
3. Garçon, N., P. Chomez, and M. Van Mechelen. 2007. GlaxoSmithKline Adjuvant Systems in vaccines: Concepts, achievements and perspectives. Expert Rev. Vaccines 6: 723-739. (Pubitemid 47607848)
4. Alderson, M. R., P. McGowan, J. R. Baldridge, and P. Probst. 2006. TLR4 agonists as immunomodulatory agents. J. Endotoxin Res. 12: 313-319. (Pubitemid 47471343)
5. Baldrick, P., D. Richardson, G. Elliott, and A. W. Wheeler. 2002. Safety evaluation of monophosphoryl lipid A (MPL): An immunostimulatory adjuvant. Regul. Toxicol. Pharmacol. 35: 398-413. (Pubitemid 35026240)
6. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801. (Pubitemid 43261452)
7. Shen, H., B. M. Tesar, W. E. Walker, and D. R. Goldstein. 2008. Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation. J. Immunol. 181: 1849-1858.
8. Hoebe, K., X. Du, P. Georgel, E. Janssen, K. Tabeta, S. O. Kim, J. Goode, P. Lin, N. Mann, S. Mudd, et al. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424: 743-748. (Pubitemid 37021696)
9. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122. (Pubitemid 29359962)
10. Lee, M. S., and Y. J. Kim. 2007. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu. Rev. Biochem. 76: 447-480.
11. Casella, C. R., and T. C. Mitchell. 2008. Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell. Mol. Life Sci. 65: 3231-3240.
12. Mata-Haro, V., C. Cekic, M. Martin, P. M. Chilton, C. R. Casella, and T. C. Mitchell. 2007. The vaccine adjuvant monophosphoryl lipid A as a TRIFbiased agonist of TLR4. Science 316: 1628-1632. (Pubitemid 46982038)
13. Cekic, C., C. R. Casella, C. A. Eaves, A. Matsuzawa, H. Ichijo, and T. C. Mitchell. 2009. Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A. J. Biol. Chem. 284: 31982-31991.
14. Haddon, D. J., F. Antignano, M. R. Hughes, M. R. Blanchet, L. Zbytnuik, G. Krystal, and K. M. McNagny. 2009. SHIP1 is a repressor of mast cell hyperplasia, cytokine production, and allergic inflammation in vivo. J. Immunol. 183: 228-236.
15. Rauh, M. J., L. M. Sly, J. Kalesnikoff, M. R. Hughes, L. P. Cao, V. Lam, and G. Krystal. 2004. The role of SHIP1 in macrophage programming and activation. Biochem. Soc. Trans. 32: 785-788. (Pubitemid 39524379)
16. March, M. E., and K. Ravichandran. 2002. Regulation of the immune response by SHIP. Semin. Immunol. 14: 37-47. (Pubitemid 34250707)
17. Sly, L. M., M. J. Rauh, J. Kalesnikoff, C. H. Song, and G. Krystal. 2004. LPSinduced upregulation of SHIP is essential for endotoxin tolerance. Immunity 21: 227-239. (Pubitemid 39094052)
18. O'Connell, R. M., A. A. Chaudhuri, D. S. Rao, and D. Baltimore. 2009. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. USA 106: 7113-7118.
19. Pedersen, I. M., D. Otero, E. Kao, A. V. Miletic, C. Hother, E. Ralfkiaer, R. C. Rickert, K. Gronbaek, and M. David. 2009. Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. EMBO Mol Med 1: 288-295.
20. Sly, L. M., M. J. Hamilton, E. Kuroda, V. W. Ho, F. L. Antignano, S. L. Omeis, C. J. van Netten-Thomas, D. Wong, H. K. Brugger, O. Williams, et al. 2009. SHIP prevents lipopolysaccharide from triggering an antiviral response in mice. Blood 113: 2945-2954.
21. Sattler, M., S. Verma, Y. B. Pride, R. Salgia, L. R. Rohrschneider, and J. D. Griffin. 2001. SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulates migration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL. J. Biol. Chem. 276: 2451-2458.
22. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92. (Pubitemid 29096240)
23. Sag, D., D. Carling, R. D. Stout, and J. Suttles. 2008. Adenosine 59- monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 181: 8633-8641.
24. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
25. + T cells and enables CpG oligodeoxynucleotide- mediated costimulation. Immunity 25: 783-793. (Pubitemid 46107281)
26. Antignano, F., M. Ibaraki, C. Kim, J. Ruschmann, A. Zhang, C. D. Helgason, and G. Krystal. 2010. SHIP is required for dendritic cell maturation. J. Immunol. 184: 2805-2813.
27. Martin, M., K. Rehani, R. S. Jope, and S. M. Michalek. 2005. Toll-like receptormediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6: 777-784. (Pubitemid 43090463)
28. Smith, H., M. Peggie, D. G. Campbell, F. Vandermoere, E. Carrick, and P. Cohen. 2009. Identification of the phosphorylation sites on the E3 ubiquitin ligase Pellino that are critical for activation by IRAK1 and IRAK4. Proc. Natl. Acad. Sci. USA 106: 4584-4590.
29. Windheim, M., M. Stafford, M. Peggie, and P. Cohen. 2008. Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinase. Mol. Cell. Biol. 28: 1783-1791.
30. Ordureau, A., H. Smith, M. Windheim, M. Peggie, E. Carrick, N. Morrice, and P. Cohen. 2008. The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1. Biochem. J. 409: 43-52.
31. Park, B. S., D. H. Song, H. M. Kim, B. S. Choi, H. Lee, and J. O. Lee. 2009. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458: 1191-1195.
32. Kim, Y. S., Z. Y. Park, S. Y. Kim, E. Jeong, and J. Y. Lee. 2009. Alteration of Toll-like receptor 4 activation by 4-hydroxy-2-nonenal mediated by the suppression of receptor homodimerization. Chem. Biol. Interact. 182: 59-66.
33. Sly, L. M., V. Ho, F. Antignano, J. Ruschmann, M. Hamilton, V. Lam, M. J. Rauh, and G. Krystal. 2007. The role of SHIP in macrophages. Front. Biosci. 12: 2836-2848.
34. Trotta, R., R. Parihar, J. Yu, B. Becknell, J. Allard, II, J. Wen, W. Ding, H. Mao, S. Tridandapani,W. E. Carson, and M. A. Caligiuri. 2005. Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood 105: 3011-3018.
35. Stöver, A. G., J. Da Silva Correia, J. T. Evans, C. W. Cluff, M. W. Elliott, E. W. Jeffery, D. A. Johnson, M. J. Lacy, J. R. Baldridge, P. Probst, et al. 2004. Structure-activity relationship of synthetic toll-like receptor 4 agonists. J. Biol. Chem. 279: 4440-4449. (Pubitemid 38199033)